A screening method for the detection of synthetic glucocorticosteroids in human urine by liquid chromatography–mass spectrometry based on class-characteristic fragmentation pathways

[1]  M. Nielen,et al.  Preventive doping control analysis: liquid and gas chromatography time-of-flight mass spectrometry for detection of designer steroids. , 2007, Rapid communications in mass spectrometry : RCM.

[2]  F. Botrè,et al.  A fast liquid chromatographic/mass spectrometric screening method for the simultaneous detection of synthetic glucocorticoids, some stimulants, anti-oestrogen drugs and synthetic anabolic steroids. , 2006, Rapid communications in mass spectrometry : RCM.

[3]  Kristin A. Sannes-Lowery,et al.  Applications of ESI-MS in drug discovery: interrogation of noncovalent complexes , 2006, Nature Reviews Drug Discovery.

[4]  M. Thevis,et al.  Screening for metabolically stable aryl-propionamide-derived selective androgen receptor modulators for doping control purposes. , 2006, Rapid communications in mass spectrometry : RCM.

[5]  M. Thevis,et al.  Analytik modifizierter Steroidhormone mittels Flüssigkeitschromatographie/Tandem-Massenspektrometrie Analysis of modified steroid hormones using liquid chromatography/tandem mass spectrometry , 2006 .

[6]  Mark Wrona,et al.  'All-in-one' analysis for metabolite identification using liquid chromatography/hybrid quadrupole time-of-flight mass spectrometry with collision energy switching. , 2005, Rapid communications in mass spectrometry : RCM.

[7]  Todd C Malvey,et al.  Tetrahydrogestrinone: The discovery of a designer steroid , 2005, Current sports medicine reports.

[8]  M. Thevis,et al.  Screening for unknown synthetic steroids in human urine by liquid chromatography-tandem mass spectrometry. , 2005, Journal of mass spectrometry : JMS.

[9]  C. Georgakopoulos,et al.  Another designer steroid: discovery, synthesis, and detection of 'madol' in urine. , 2005, Rapid communications in mass spectrometry : RCM.

[10]  Yu-Chen Chang,et al.  Tetrahydrogestrinone: discovery, synthesis, and detection in urine. , 2004, Rapid communications in mass spectrometry : RCM.

[11]  Francesco Botrè,et al.  Drugs of abuse and abuse of drugs in sportsmen: the role of in vitro models to study effects and mechanisms. , 2003, Toxicology in vitro : an international journal published in association with BIBRA.

[12]  D. Catlin,et al.  Detection of norbolethone, an anabolic steroid never marketed, in athletes' urine. , 2002, Rapid communications in mass spectrometry : RCM.

[13]  Andrew J. Hutt,et al.  Recent Advances in Doping Analysis , 2002 .

[14]  G Mannens,et al.  Strategies for absorption screening in drug discovery and development. , 2001, Current topics in medicinal chemistry.

[15]  F. Molaioni,et al.  Detection of beta-blockers in human urine by GC-MS-MS-EI: perspectives for the antidoping control. , 2000, Journal of pharmaceutical and biomedical analysis.

[16]  B. Le Bizec,et al.  Collision-induced dissociation of corticosteroids in electrospray tandem mass spectrometry and development of a screening method by high performance liquid chromatography/tandem mass spectrometry. , 2000, Rapid communications in mass spectrometry : RCM.

[17]  Pietro Traldi,et al.  Rapid Commun. Mass Spectrom.10. 1629-1637 (1996) Matrix-assisted Laser Desorption/Ionisation Mass Spectrometry in Milk Science , 1997 .

[18]  Roger L. Black,et al.  Goodman and Gilman's The Pharmacological Basis of Therapeutics , 1991 .